Raymond James Financial Aktie 966260 / US7547301090
162.60
USD
-0.86
USD
-0.53%
19.11.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Raymond James Financial Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2024 | Raymond James Financial Inc. | 1.47 | 1.80 | USD |
| 2023 | Raymond James Financial Inc. | 1.67 | 1.68 | USD |
| 2022 | Raymond James Financial Inc. | 1.38 | 1.36 | USD |
| 2021 | Raymond James Financial Inc. | 1.13 | 1.04 | USD |
| 2020 | Raymond James Financial Inc. | 2.03 | 0.99 | USD |
| 2019 | Raymond James Financial Inc. | 1.65 | 0.91 | USD |
| 2018 | Raymond James Financial Inc. | 1.20 | 0.73 | USD |
| 2017 | Raymond James Financial Inc. | 1.04 | 0.59 | USD |
| 2016 | Raymond James Financial Inc. | 1.37 | 0.53 | USD |
| 2015 | Raymond James Financial Inc. | 1.45 | 0.48 | USD |
Gewinn je Aktie- Raymond James Financial
| 3.8 18 | 4.8 19 | 3.9 20 | 6.6 21 | 7.0 22 | 8.0 23 | 9.7 24 |
Umsatz je Aktie- Raymond James Financial
| 33.4 18 | 37.0 19 | 39.0 20 | 46.8 21 | 51.9 22 | 60.0 23 | 70.3 24 |
KGV- Raymond James Financial
| 16.0 18 | 11.5 19 | 12.5 20 | 13.9 21 | 14.2 22 | 12.6 23 | 12.6 24 |
Raymond James Financial Inc.: Die Aktie (in USD)
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 3.83 | 4.78 | 3.89 | 6.63 | 6.98 | 7.97 | 9.70 |
| Gewinn je Aktie unverwässert | 3.93 | 4.88 | 3.96 | 6.81 | 7.16 | 8.16 | 9.96 |
| Gewinn je Aktie verwässert | 3.83 | 4.78 | 3.88 | 6.63 | 6.98 | 7.97 | 9.70 |
| Dividende pro Aktie | 0.73 | 0.91 | 0.99 | 1.04 | 1.36 | 1.68 | 1.80 |
| Gesamtdividendenausschüttung in Mio. | 151.34 | 191.00 | 205.00 | 218.00 | 277.00 | 355.00 | - |
Raymond James Financial Inc.: Unternehmenskennzahlen (in USD)
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 33.41 | 36.97 | 38.98 | 46.76 | 51.91 | 60.00 | 70.29 |
| KGV (Jahresendkurs, EPS unverwässert) | 16.01 | 11.51 | 12.49 | 13.91 | 14.17 | 12.61 | 12.62 |
| KGV (Jahresendkurs, EPS verwässert) | 16.01 | 11.51 | 12.49 | 13.91 | 14.17 | 12.61 | 12.62 |
| KGV (Jahresendkurs) | 16.01 | 11.51 | 12.49 | 13.91 | 14.17 | 12.61 | 12.62 |
| Dividendenrendite Jahresende in % | 1.20 | 1.65 | 2.03 | 1.13 | 1.38 | 1.67 | 1.47 |
| Eigenkapitalquote in % | 17.20 | 17.07 | 15.04 | 13.36 | 11.65 | 13.00 | 13.97 |
| Fremdkapitalquote in % | 82.80 | 82.93 | 84.96 | 86.64 | 88.35 | 87.00 | - |
Raymond James Financial Inc.: GuV (in Mio. USD)
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 7’458.58 | 7’986.00 | 8’198.00 | 9’876.00 | 11’176.00 | 13’013.00 | 14’923.00 |
| Umsatzveränderung in % | 14.01 | 7.07 | 2.65 | 20.47 | 13.16 | 16.44 | 14.68 |
| Bruttoergebnis vom Umsatz | 7’160.01 | 7’511.00 | 7’814.00 | 9’465.00 | 10’557.00 | 11’453.00 | 14’741.00 |
| Bruttoergebnisveränderung in % | 13.97 | 4.90 | 4.03 | 21.13 | 11.54 | 8.49 | 28.71 |
| Operatives Ergebnis | 1’399.59 | 1’469.00 | 1’203.00 | 2’004.00 | 2’136.00 | 2’409.00 | 4’745.00 |
| Veränderung Operatives Ergebnis in % | 29.80 | 4.96 | -18.11 | 66.58 | 6.59 | 12.78 | 96.97 |
| Ergebnis vor Steuern | 1’304.88 | 1’375.00 | 1’052.00 | 1’791.00 | 2’022.00 | 2’280.00 | 2’643.00 |
| Veränderung Ergebnis vor Steuern in % | 40.62 | 5.37 | -23.49 | 70.25 | 12.90 | 12.76 | 15.92 |
| Ergebnis nach Steuer | 855.23 | 1’032.00 | 817.00 | 1’401.00 | 1’506.00 | 1’734.00 | 2’068.00 |
| Veränderung Ergebnis nach Steuer in % | 34.71 | 20.67 | -20.83 | 71.48 | 7.49 | 15.14 | 19.26 |
Raymond James Financial Inc.: Bilanz (in Mio. USD)
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 31’063 | 32’279 | 40’531 | 53’853 | 71’519 | 68’173 | - |
| Langzeit Gesamtverbindlichk. pro Aktie | - | - | - | - | - | - | - |
| Eigenkapital | 6’452 | 6’643 | 7’176 | 8’303 | 9’432 | 10’187 | 11’594 |
| Veränderung Eigenkapital in % | 14.10 | 3.34 | 8.10 | 15.90 | 13.26 | 8.54 | 14.40 |
| Bilanzsumme | 37’516 | 38’922 | 47’707 | 62’156 | 80’951 | 78’360 | - |
| Veränderung Bilanzsumme in % | 7.37 | 3.75 | 22.57 | 30.29 | 30.24 | -3.20 | - |
Raymond James Financial Inc.: Sonstige Angaben (in USD)
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 3.93 | 4.88 | 3.96 | 6.81 | 7.16 | 8.16 | 9.96 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 32.96 | 24.26 | -18.88 | 72.07 | 5.06 | 14.01 | 22.10 |
| Gewinn je Aktie (verwässert) | 3.83 | 4.78 | 3.88 | 6.63 | 6.98 | 7.97 | 9.70 |
| Veränderung Gewinn je Aktie (verwässert) in % | 32.79 | 24.64 | -18.69 | 70.75 | 5.17 | 14.20 | 21.76 |
| Anzahl Mitarbeiter | 18’550 | 18’910 | 19’635 | 20’021 | 22’043 | 23’019 | - |
| Veränderung Anzahl Mitarbeiter in % | 9.12 | 1.94 | 3.83 | 1.97 | 10.10 | 4.43 | - |
Raymond James Financial Inc. Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Raymond James Financial Inc. | Quartalszahlen | 29.01.2025 |
| Raymond James Financial Inc. | Quartalszahlen | 23.04.2025 |
| Raymond James Financial Inc. | Quartalszahlen | 23.07.2025 |
| Raymond James Financial Inc. | Quartalszahlen | 28.10.2025 |
| Raymond James Financial Inc. | Quartalszahlen | 28.01.2026 |
| Raymond James Financial Inc. | Quartalszahlen | 29.04.2026 |
| Raymond James Financial Inc. | Quartalszahlen | 29.07.2026 |
| Raymond James Financial Inc. | Quartalszahlen | 28.10.2026 |
Raymond James Financial Inc. vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q4 2024 Earnings Release | 23.10.2024 |
| Quartalszahlen | Q3 2024 Earnings Release | 24.07.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 24.04.2024 |
| Hauptversammlung | Annual General Meeting | 22.02.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 24.01.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 25.10.2023 |
| Quartalszahlen | Q3 2023 Earnings Release | 26.07.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 26.04.2023 |
| Hauptversammlung | Annual General Meeting | 23.02.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 25.01.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 26.10.2022 |
| Quartalszahlen | Q3 2022 Earnings Release | 27.07.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 27.04.2022 |
| Hauptversammlung | Annual General Meeting | 24.02.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 26.01.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 89.97 |
| The Vanguard Group, Inc. | 10.97 |
| Vanguard Group, Inc. (Subfiler) | 10.38 |
| Thomas Alan James | 9.51 |
| PRIMECAP Management Co. | 6.06 |
| PRIMECAP Management Co. | 5.89 |
| Wellington Management Co. LLP | 5.55 |
| Wellington Management Co. LLP (Wellington Breakout) | 5.33 |
| State Street Corp. | 3.92 |
| Vanguard Total Stock Market ETF | 2.88 |
| BlackRock Fund Advisors | 2.70 |
| Fidelity Management & Research Co. LLC | 2.42 |
| Vanguard 500 Index Fund | 2.39 |
| Geode Capital Management LLC | 2.14 |
| Vanguard PRIMECAP Fund | 2.12 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 19’635 | 20’021 | 22’043 | 23’019 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.42 | 0.49 | 0.51 | 0.57 | 0.00 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 0 | 0 | 0 | 0 | 0 |
| Summe Anlagevermögen | 0 | 0 | 0 | 0 | 0 |
| Summe Aktiva | 47’707 | 62’156 | 80’951 | 78’360 | 82’992 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 3’528 | 3’622 | 4’277 | 4’015 | 0 |
| Summe Fremdkapital | 40’531 | 53’853 | 71’519 | 68’173 | 0 |
| Summe Eigenkapital | 7’176 | 8’303 | 9’432 | 10’187 | 11’594 |
| Summe Passiva | 47’707 | 62’156 | 80’951 | 78’360 | 0 |
Adresse
| 880 Carillon Parkway, 33716 St. Petersburg | |
| Telefon | +1 (727) 567-1000 |
| URL | http://www.raymondjames.com |
Management
|
Andy Zolper
Chief Information Technology Security Officer |
|
Anne Gates
Independent Non-Executive Director |
|
Art A. Garcia
Independent Non-Executive Director |
|
Bella Loykhter Allaire
Chief Administrative Officer |
|
Benjamin C. Esty
Independent Non-Executive Director |
|
Bradley Ward Sussman
VP-Alternative Investments Product Development |
|
Calvin Sullivan
Chief Strategy Officer-Fixed Income Division |
|
Cecily Mistarz
Independent Director |
|
Chad Runnels
Senior Vice President |
|
Chris Aisenbrey
Chief Human Resources Officer |
|
Chuck Ellingsworth
Managing Director |
|
David De Luca
Senior Managing Director & Head-Global Equities |
|
Doug Brigman
Complex Manager & Senior VP-Investments |
|
Gavin Murrey
Executive Vice President & Head-Public Finance |
|
George Catanese
Chief Risk Officer |
|
Gordon L. Johnson
Independent Non-Executive Director |
|
Guy Logan
Managing Director-Atlanta Region |
|
Horace Carter
President-Fixed Income |
|
Jack A. Dudick
MD-Healthcare Finance Gp, Head-Healthcare Real Est |
|
James E. Bunn
President-Capital Markets |
|
Jay Hernandez
Managing Director-Boston |
|
Jeffrey N. Edwards
Lead Independent Non-Executive Director |
|
Jonathan N. Santelli
Secretary, Executive VP & General Counsel |
|
Jonathan Oorlog
Chief Financial Officer |
|
K. Gregory Rust
Senior Vice President-Operations |
|
Katherine H. Larson
Chief Accounting Officer |
|
Kevin J. Kooman
Managing Director-Investment Banking |
|
Kristina R. Waugh
Vice President-Investor Relations |
|
Leslie Ann Curry
Chief Experience Officer-Investment Banking |
|
Marlene B. Debel
Independent Non-Executive Director |
|
Mike White
Chief Marketing Officer |
|
Parker Colvin
Managing Director |
|
Paul C. Reilly
Chairman |
|
Paul M. Shoukry
President, Chief Executive Officer & Director |
|
Raj Seshadri
Independent Non-Executive Director |
|
Raymond W. McDaniel
Independent Non-Executive Director |
|
Roderick C. McGeary
Independent Non-Executive Director |
|
Scott Alan Curtis
Chief Operating Officer |
|
Steve LaBarbera
Chief Compliance Officer |
|
Stuart Barich
Managing Dir-Life Sciences Investment Banking Team |
|
TJ Haynes-Morgan
Chief Audit Executive |
|
Tarek Helal
Chief Risk Officer & SVP-Corporate Risk Management |
|
Tashtego Spring Elwyn
President-Private Client Group |
|
Vin Campagnoli
Chief Information Officer |